Presentation of ALS Survival Benefits at the 35th International Symposium on ALS/MND
Dec 6, 2024
Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2024 Clene Nanomedicine, Inc. - All rights reserved | PRIVACY POLICY | TERMS OF USE